Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa
Sponsor: PT. Prodia Stem Cell Indonesia
Summary
The study will perform to follow-up UC-MSCs and CM transplantation. 18 patients will be called back to be examined after 5 years of UC-MSC and/or CM transplantation.
Official title: Long-term Safety of Umbilical Cord-Mesenchymal Stem Cell (UC-MSC) Transplantation in Patients With Retinitis Pigmentosa
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
OBSERVATIONAL
Enrollment
18
Start Date
2026-05
Completion Date
2027-09
Last Updated
2026-02-25
Healthy Volunteers
No
Conditions
Interventions
Conditioned Medium (CM)
Conditioned Medium (CM) injected by peribulbar
Umbilical Cord Mesenchymal Stem Cell (UC-MSC)
Umbilical Cord Mesenchymal Stem Cell (UC-MSC) injected by peribulbar
Locations (2)
Jakarta Eye Center Hospital
Jakarta, DKI Jakarta, Indonesia
Sardjito Hospital
Yogyakarta, Special Region, Indonesia